Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
7 papers
Recent·Most cited
S. R. Rao, C. Verrill, L. Cerundolo…·F. C. Hamdy
This study integrates multi-region whole genome sequencing with histopathological data to reconstruct tumour phylogenies and identify molecular steps in prostate cancer progression and metastasis.
C. Y. Mah, A. D. T. Nguyen, T. Niijima…·L. M. Butler
This study identifies DECR2 as a key driver of treatment resistance in advanced prostate cancer by regulating lipid metabolism and cell cycle progression.
S. Taavitsainen, N. Engedal, S. Cao…·A. Urbanucci
The paper uses single-cell ATAC and RNA sequencing to identify pre-existing and treatment-persistent stem-like cell subpopulations in prostate cancer models that predict treatment response.
H. T. Sjoberg, Y. J. Philippou, A. L. Magnussen…·R. J. Bryant
This paper investigates combining fractionated radiotherapy with vascular-targeted photodynamic therapy to enhance tumor control in preclinical prostate cancer models.
J. L. Gillis, J. A. Hinneh, N. K. Ryan…·L. M. Butler
This study identifies a feedback loop between the androgen receptor and 6PGD that drives prostate cancer growth and shows that targeting both improves therapeutic efficacy.
C. W. D. Armstrong, J. A. Coulter, C. W. Ong…·D. J. J. Waugh
This study identifies PTEN-deficiency-associated CXC-chemokine signaling as a driver of radiotherapy resistance in prostate cancer and shows that targeting CXCR1/2 improves radiotherapy outcomes.
M. J. Dunning, S. L. Vowler, E. Lalonde…·A. D. Lamb
The paper introduces a web-based platform called 'camcAPP' to facilitate access and analysis of human prostate cancer genomic datasets from two cohorts.